News

Jeff Liter, CEO of Luminary Therapeutics discusses the company's unique approach in the fast-evolving landscape of cancer treatment.

IgniteData will provide data transfer integration between the EHR at MSK and the electronic systems of two major clinical trial sponsors.

Eko Health developed the device, which has received 501(k) clearance from the FDA.

In an interview at the DIA Global Annual Meeting with Nicholas Saraceno, Venkatraman Balasubramanian, SVP and global head, industry solutions, healthcare and life sciences, Orion Innovation, discusses feedback from the audience during his session, “The Case for Generating Synthetic Data as Real-World Data: Regulatory and Planning Perspectives.”

In an interview at the DIA Global Annual Meeting with Nicholas Saraceno, Venkatraman Balasubramanian, SVP and global head, industry solutions, healthcare and life sciences, Orion Innovation, provides a synopsis of "“The Case for Generating Synthetic Data as Real-World Data: Regulatory and Planning Perspectives.”

In an interview at the DIA Global Annual Meeting with Nicholas Saraceno, Courtney Granville, Director, Scientific Affairs, Drug Information Association, discusses issues that will be addressed at the upcoming FDA town hall.

In an interview at the DIA Global Annual Meeting with Nicholas Saraceno, Courtney Granville, Director, Scientific Affairs, Drug Information Association, discusses analyzing AI in Regulatory Decision Making

Partnership will support imaging in oncology clinical trials.

In an interview at the DIA Global Annual Meeting with Nicholas Saraceno, Tamei Elliott, Senior Manager, Scientific Programs, Drug Information Association, discussed inroads in clinical trials for underserved populations.

In an interview at the DIA Global Annual Meeting with Nicholas Saraceno, Tamei Elliott, Senior Manager, Scientific Programs, Drug Information Association, discusses DIA educational opportunities improving clinical operations staff on DE&I concerns.

In an interview at the DIA Global Annual Meeting with Nicholas Saraceno, Tamei Elliott,Senior Manager, Scientific Programs, Drug Information Association, discusses changes to the role of diversity in clinical trials in regard to scientific programing.

In an interview at the DIA Global Annual Meeting with Nicholas Saraceno, Cal Collins, CEO of OpenClinica discusses the near-term and long-term future of SMART on FHIR.

In an interview at the DIA Global Annual Meeting with Nicholas Saraceno, Cal Collins, CEO of OpenClinica discusses the current state of SMART on FHIR and its impact on the usefulness of real-world data.

In an interview at the DIA Global Annual Meeting with Nicholas Saraceno, Cal Collins, CEO of OpenClinica discusses his passion for SMART on FHIR.

Integrated eCOA & ePRO solution taps company’s technology expertise.

DIA session offers an overview of the current regulatory landscape and challenges for both sponsors and regulators in achieving quality and integrity in the fast-moving area.

Collaboration to focus on digital vascular biomarker patient monitoring trial.

First guidance in this area from the Agency addresses the unique challenges when designing clinical studies for these drugs

ICH unveils new draft guidance on good clinical practice, with the aim of aligning trial conduct with advancing life sciences innovation and technology.

Addition solidifies commitment to delivering comprehensive solutions worldwide, company says.

Study Health Check provides early identification of issues related to protocol deviations and determines objective measures of site-specific versus study-wide performance.

Suite of AI-enhanced SaaS solutions address many functions within clinical development.

FDA’s new voluntary pilot program is designed to help clinicians select appropriate cancer treatments for patients.

New partnership brings 15,000 members to participate in AOD membership.

Virtual CRO seeks to help life sciences companies meet new federal guidelines for diversity, equity, and inclusion in clinical trials.

Expansion into UK marks company’s third international subsidiary.

Latest number of infectious disease clinical trials from ClinicalTrials.gov.

New toolkit to standardize guidelines for streamlined IRB/Ethics review of DCT applications.